Incidence rates of treatment-emergent adverse events and related hospitalization are reduced with azacitidine compared with conventional care regimens in older patients with acute myeloid leukemia

Erstveröffentlichung

2017

Authors

Seymour, John F.

Döhner, Hartmut

Minden, Mark D.

Stone, Richard

Gambini, Dominique

et al.

Wissenschaftlicher Artikel

Published in

Leukemia & Lymphoma ; 58 (2017), 6. - S. 1412-1423. - ISSN 1042-8194. - eISSN 1029-2403

Link to publication

https://dx.doi.org/10.1080/10428194.2016.1243680

Institutions

UKU. Klinik für Innere Medizin III

Subject headings

[Free subject headings]: Azacitidine | hospitalization | treatment-emergent adverse event | AE | TEAE | risk myelodysplastic syndromes | dna methyltransferase inhibitors | quality-of-life | management | adults | 5-azacytidine | mortality | diagnosis | cells | time
[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record